During EMT, cancer cells alter a series of gene expressions, including downregulation of epithelial markers (e.g. E-cadherin) and upregulation of mesenchymal markers (e.g. N-cadherin and vimentin) 4. The gene discussed is CDH1; the disease is cancer.